Verona Pharma Ltd

📅 Upcoming

🕒 Recent(90d)

News

• Frazier adds $1.1B+ to small and mid-sized biotech fund
  Frazier’s life science fund has already benefited several successful biotechs, including Verona Pharma, which was acquired by Merck for $10 billion, and Carmot Therapeutics, which Roche bought for…
  biospace · 22d ago
• Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs
  Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused capital commitment, netting more than $1.1 billion for its long-running public fund.
  fiercebiotech · 23d ago
• A COPD drug from China draws $115M in venture funding
  Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.
  biopharma_dive · 1mo ago
• Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss
  The anti-TL1A antibody from Merck's 2023 Prometheus buy delivered positive mid-stage results in a skin condition but failed in a certain type of lung disease, the Big Pharma revealed alongside seco…
  biospace · 2mo ago
• AstraZeneca, GSK intensify China ties with Sino Biopharm deals
  The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.
  biopharma_dive · 2mo ago
• Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
  Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to investors, some say.
  biopharma_dive · 5mo ago